Dashboard
Manage Tickers

ANNXAnnexon, Inc.

Nasdaq annexonbio.com


$ 4.83 $ 0.18 (3.87 %)    

Thursday, 27-Jun-2024 15:59:58 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 482.07 $ 2.09 (0.44 %)
DIA $ 391.62 $ 0.38 (0.1 %)
SPY $ 546.37 $ 0.86 (0.16 %)
TLT $ 93.57 $ 0.14 (0.15 %)
GLD $ 215.08 $ 2.50 (1.18 %)
$ 4.65
$ 4.64
$ 0.00 x 0
$ 0.00 x 0
$ 4.52 - $ 5.08
$ 1.57 - $ 8.40
3,980,144
na
570.43M
$ 1.17
$ 42.25
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-13-2024 03-31-2024 10-Q
2 03-26-2024 12-31-2023 10-K
3 11-13-2023 09-30-2023 10-Q
4 08-07-2023 06-30-2023 10-Q
5 05-08-2023 03-31-2023 10-Q
6 03-06-2023 12-31-2022 10-K
7 11-03-2022 09-30-2022 10-Q
8 08-08-2022 06-30-2022 10-Q
9 05-09-2022 03-31-2022 10-Q
10 03-01-2022 12-31-2021 10-K
11 11-09-2021 09-30-2021 10-Q
12 08-16-2021 06-30-2021 10-Q
13 05-17-2021 03-31-2021 10-Q
14 03-25-2021 12-31-2020 10-K
15 11-16-2020 09-30-2020 10-Q
16 09-08-2020 06-30-2020 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

annexon-shares-are-trading-higher-after-the-company-announced-that-it-presented-results-from-the-phase-3-trial-of-c1q-targeted-immunotherapy-anx005-in-guillain-barr-syndrome-at-the-2024-peripheral-nerve-society-annual-meeting
Annexon shares are trading higher after th...
06/26/2024 11:47:25

annexon-presents-results-from-completed-pivotal-phase-3-trial-of-c1q-targeted-immunotherapy-anx005-in-guillain-barr-syndrome
Annexon Presents Results From Completed Pi...
06/25/2024 21:02:19

Key Findings from the Phase 3 GBS Trial of ANX005 30 mg/kg Treatment Phase 3 trial informed by dose-ranging Phase 1b trial, ...

annexon-to-present-significant-phase-3-results-of-anx005-in-guillain-barr-syndrome-at-pns-annual-meeting-potential-to-be-first-targeted-therapy-for-gbs
Annexon to Present Significant Phase 3 Res...
06/18/2024 12:16:01

reported-earlier-annexon-prices-125m-underwritten-public-offering-of-13001120-common-shares-at-625share
Reported Earlier, Annexon Prices $125M Und...
06/06/2024 06:12:34

The pricing of its previously announced underwritten public offering of 13,001,120 shares of its common stock at a price to the...

cantor-fitzgerald-reiterates-overweight-on-annexon
Cantor Fitzgerald Reiterates Overweight on...
06/05/2024 13:55:14

Cantor Fitzgerald analyst Pete Stavropoulos reiterates Annexon (NASDAQ:ANNX) with a Overweight.

douyu-international-posts-q1-results-joins-annexon-dollar-tree-and-other-big-stocks-moving-lower-in-wednesdays-pre-market-session
DouYu International Posts Q1 Results, Join...
06/05/2024 12:07:39

annexon-shares-are-trading-lower-after-the-company-announced-the-commencement-of-a-125-million-public-offering
Annexon shares are trading lower after the...
06/05/2024 12:07:23

why-stitch-fix-shares-are-trading-higher-by-18-here-are-20-stocks-moving-premarket
Why Stitch Fix Shares Are Trading Higher B...
06/05/2024 09:27:25

annexon-commences-public-offering-of-125m-of-shares-of-its-common-stock
Annexon Commences Public Offering Of $125M...
06/04/2024 21:09:36

All of the shares are being offered by Annexon. In addition, Annexon expects to grant the underwriters a 30-day option to purch...

needham-reiterates-buy-on-annexon-maintains-16-price-target
Needham Reiterates Buy on Annexon, Maintai...
06/04/2024 19:16:54

Needham analyst Joseph Stringer reiterates Annexon (NASDAQ:ANNX) with a Buy and maintains $16 price target.

hc-wainwright--co-reiterates-buy-on-annexon-maintains-30-price-target
HC Wainwright & Co. Reiterates Buy on Anne...
06/04/2024 18:57:42

HC Wainwright & Co. analyst Andrew Fein reiterates Annexon (NASDAQ:ANNX) with a Buy and maintains $30 price target.

dow-surges-200-points-designer-brands-shares-plunge-following-q1-earnings
Dow Surges 200 Points; Designer Brands Sha...
06/04/2024 18:32:30

why-core--main-shares-are-trading-lower-by-11-here-are-other-stocks-moving-in-tuesdays-mid-day-session
Why Core & Main Shares Are Trading Lower B...
06/04/2024 16:54:09

12-health-care-stocks-moving-in-tuesdays-intraday-session
12 Health Care Stocks Moving In Tuesday's ...
06/04/2024 16:31:07

mid-cap-firm-annexons-nerve-disorder-candidate-shows-promise-in-pivotal-late-stage-study
Mid-Cap Firm Annexon's Nerve Disorder Cand...
06/04/2024 16:06:20

Annexon reports positive Phase 3 trial results for ANX005 in Guillain-Barré syndrome, showing significant improvements in disab...

gold-down-1-bath--body-works-shares-tumble-after-q1-results
Gold Down 1%; Bath & Body Works Shares Tum...
06/04/2024 16:00:38

saia-annexon-core-scientific-and-other-big-stocks-moving-higher-on-tuesday
Saia, Annexon, Core Scientific And Other B...
06/04/2024 14:08:59

Core News & Articles
Market-Moving News for June 4th
06/04/2024 12:36:59

AX: -21% | Watching Axos Financial; Hindenburg Research Issues Report On Co Titled "Axos: Glaring Commercial Real Estate Lo...

12-health-care-stocks-moving-in-tuesdays-pre-market-session
12 Health Care Stocks Moving In Tuesday's ...
06/04/2024 12:06:42

annexon-says-anx005-75-mgkg-outperformed-placebo-on-multiple-endpoints-however-it-was-not-statistically-significant-on-the-primary-endpoint-of-gbs-ds-at-week-8
Annexon Says "ANX005 75 mg/kg outperformed...
06/04/2024 11:03:42

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

06/28/2024 Malibu Boats, Inc. (MBUU)
07/01/2024 Globe Life Inc. f/k/a Torchmark Corporation (GL)
07/01/2024 Equinix, Inc. (EQIX)
07/02/2024 Intel Corporation (INTC)
07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)

NEW CASE INVESTIGATION

Ooma Inc (OOMA) AnaptysBio Inc (ANAB)